Buy One Get One free -Llimited Time Offer X
Lamostad 30 Tablet is a commercial drug that is prescribed in the form of Tablet. Secondary and off-label uses of Lamostad 30 Tablet have also been mentioned below.
The correct dosage of Lamostad 30 Tablet depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Lamostad 30 Tablet as well, which are listed below. Such side effects of Lamostad 30 Tablet normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Lamostad 30 Tablet has a Moderate effect for pregnant women and Mild effect on lactating mothers. Warnings related to Lamostad 30 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Lamostad 30 Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Lamostad 30 Tablet in conditions like Kidney Disease, Pancreatitis, Liver Disease. Other conditions have been mentioned below in the Lamostad 30 Tablet contraindications section.
Additionally, Lamostad 30 Tablet may also adversely react with other medicines. A complete list of these interactions is given below.
You should also be aware that Lamostad 30 Tablet is not safe while driving, and is not addiction.
Lamostad 30 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Based on research, the following side effects have been observed when Lamostad 30 Tablet is used -
Moderate
Mild
Is the use of Lamostad 30 Tablet safe for pregnant women?
Lamostad may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Lamostad again without your doctor's advice.
Is the use of Lamostad 30 Tablet safe during breastfeeding?
Breastfeeding women can take Lamostad as it bears very minor side effects for them.
What is the effect of Lamostad 30 Tablet on the Kidneys?
Lamostad has very mild side effects on the kidneys.
What is the effect of Lamostad 30 Tablet on the Liver?
Very few cases of side effects of Lamostad on the liver have been reported.
What is the effect of Lamostad 30 Tablet on the Heart?
There are no any side effects of Lamostad for the heart.
If you are suffering from any of the following diseases, you should not take Lamostad 30 Tablet unless your doctor advises you to do so -
Is this Lamostad 30 Tablet habit forming or addictive?
No, you will not get addicted to Lamostad 30 Tablet.
Interaction between Food and Lamostad 30 Tablet
Taking Lamostad 30 Tablet with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Lamostad 30 Tablet
Consumption of alcohol and Lamostad 30 Tablet together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Epivir (lamivudine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 807-808
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 96-99
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zerit® (stavudine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 807